Section Arrow
XGN.NASDAQ
- Exagen
Quotes are at least 15-min delayed:2025/07/02 07:12 EDT
Last
 6.99
+0.01 (+0.14%)
Day High 
Prev. Close
6.98 
1-M High
7.95 
Volume 
149.23K 
Bid
6.29
Ask
7.47
Day Low
6.68 
Open
6.91 
1-M Low
6.6 
Market Cap 
152.59M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 7.15 
20-SMA 7.19 
50-SMA 6.51 
52-W High 7.95 
52-W Low 1.71 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.84/-0.28
Enterprise Value
174.07M
Balance Sheet
Book Value Per Share
0.29
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
55.64M
Operating Revenue Per Share
2.42
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NEOGNeogen Corp5.08+0.3+6.28%879PE
DHRDanaher Corp201.1+3.56+1.80%38.28PE
ILMNIllumina98.15+2.74+2.87%-- 
EXASExact Sciences Corp54.6+1.46+2.75%-- 
TMOThermo Fisher Scientific421.47+16.01+3.95%23.46PE
Quotes are at least 15-min delayed:2025/07/02 07:12 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.